Mr. Van Naarden serves as an Analyst
of Aisling Capital. Previously, Mr. Van Naarden was an
Analyst in the Healthcare Group of Goldman Sachs’s
Investment Banking Division, where he worked closely
with management of companies across the worldwide
healthcare industry, primarily in pharmaceuticals and
biotechnology, in the evaluation and execution of
acquisitions, financings, and corporate strategy.
Mr. Van Naarden received his A.B. from Princeton
University, awarded Phi Beta Kappa and magna cum laude
in molecular biology.